Literature DB >> 16195786

Human ribosomal protein L18a interacts with hepatitis C virus internal ribosome entry site.

D Dhar1, K Mapa, R Pudi, P Srinivasan, K Bodhinathan, S Das.   

Abstract

Translation initiation of hepatitis C virus RNA occurs via ribosome binding to an 'internal ribosome entry site (IRES)' located in the 5'untranslated region of the viral RNA. The principle interaction between the 40S ribosomal subunit and the HCV IRES has been shown to be largely factor independent, which is followed by the joining of the 60S ribosomal subunit to form functional 80S complex. However several additional cellular proteins have been reported to bind to HCV IRES and enhance the initiation of translation. In order to identify novel factors involved in the ribosome assembly during internal initiation of HCV RNA, northwestern screening of a HeLa cDNA expression library was performed, using HCV IRES RNA as probe. We demonstrate here, that human ribosomal protein L18a, a constituent of 60S subunit, interacts with HCV IRES RNA. This interaction was further confirmed by using a recombinant protein similar to L18a (sL18a), cloned from human blood. Interestingly, addition of increasing concentration of the purified recombinant sL18a protein, showed moderate stimulation of HCV IRES activity in the in vitro translation assay. These observations suggest that the human L18a might influence the HCV IRES mediated translation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16195786     DOI: 10.1007/s00705-005-0642-6

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  9 in total

1.  Evidence for separation of HCV subtype 1a into two distinct clades.

Authors:  B E Pickett; R Striker; E J Lefkowitz
Journal:  J Viral Hepat       Date:  2010-06-21       Impact factor: 3.728

2.  Deletion of a subgroup of ribosome-related genes minimizes hypoxia-induced changes and confers hypoxia tolerance.

Authors:  Ajit N Shah; Daniela Cadinu; R Michael Henke; Xiantong Xin; Ranita Ghosh Dastidar; Li Zhang
Journal:  Physiol Genomics       Date:  2011-05-17       Impact factor: 3.107

Review 3.  HTLV-1 Yin and Yang: Rex and p30 master regulators of viral mRNA trafficking.

Authors:  Hicham H Baydoun; Marcia Bellon; Christophe Nicot
Journal:  AIDS Rev       Date:  2008 Oct-Dec       Impact factor: 2.500

Review 4.  Fatal attraction: The roles of ribosomal proteins in the viral life cycle.

Authors:  Clare M Miller; Sangeetha Selvam; Gabriele Fuchs
Journal:  Wiley Interdiscip Rev RNA       Date:  2020-07-12       Impact factor: 9.957

5.  QTL analysis of cocoon shell weight identifies BmRPL18 associated with silk protein synthesis in silkworm by pooling sequencing.

Authors:  Chunlin Li; Xiaoling Tong; Weidong Zuo; Yue Luan; Rui Gao; Minjin Han; Gao Xiong; Tingting Gai; Hai Hu; Fangyin Dai; Cheng Lu
Journal:  Sci Rep       Date:  2017-12-21       Impact factor: 4.379

6.  SNHG8 is identified as a key regulator of epstein-barr virus(EBV)-associated gastric cancer by an integrative analysis of lncRNA and mRNA expression.

Authors:  Tao Huang; Yan Ji; Dan Hu; Baozheng Chen; Hejun Zhang; Chao Li; Gang Chen; Xingguang Luo; Xiong-Wei Zheng; Xiandong Lin
Journal:  Oncotarget       Date:  2016-12-06

Review 7.  Minding the message: tactics controlling RNA decay, modification, and translation in virus-infected cells.

Authors:  Hannah M Burgess; Elizabeth I Vink; Ian Mohr
Journal:  Genes Dev       Date:  2022-02-01       Impact factor: 12.890

8.  Mutant Presenilin 1 Dysregulates Exosomal Proteome Cargo Produced by Human-Induced Pluripotent Stem Cell Neurons.

Authors:  Sonia Podvin; Alexander Jones; Qing Liu; Brent Aulston; Charles Mosier; Janneca Ames; Charisse Winston; Christopher B Lietz; Zhenze Jiang; Anthony J O'Donoghue; Tsuneya Ikezu; Robert A Rissman; Shauna H Yuan; Vivian Hook
Journal:  ACS Omega       Date:  2021-05-13

9.  Translational control of the interferon regulatory factor 2 mRNA by IRES element.

Authors:  Debojyoti Dhar; Swagata Roy; Saumitra Das
Journal:  Nucleic Acids Res       Date:  2007-08-13       Impact factor: 16.971

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.